RNAZ Stock Analysis: Buy, Sell, or Hold?
RNAZ - TransCode Therapeutics, Inc. Common Stock
$9.49
-0.99 (-9.42%)
▼
5d:
-3.85%
30d:
+47.36%
90d:
-25.22%
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Get Alerted When RNAZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: RNAZ shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: RNAZ shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: RNAZ is currently trading at $9.49, which is considered slightly high relative to its 30-day fair value range of $7.09 to $10.23.
Technical Outlook: Technically, RNAZ is in a downtrend. Immediate support is located at $8.35, while resistance sits at $12.60. Short-term momentum is weak, with the stock down 9.4% recently.
Market Sentiment: RNAZ has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RNAZ is in a downtrend. Immediate support is located at $8.35, while resistance sits at $12.60. Short-term momentum is weak, with the stock down 9.4% recently.
Market Sentiment: RNAZ has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$7.09 -
$10.23
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.4%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.4%)
- NEUTRAL: Near Wall St target ($10.00)
Fair Price Analysis
30-Day Fair Range
$7.09 -
$10.23
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$8.35
Resistance Level
$12.60
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-29.66
Wall Street Target
$10.00
(+5.4%)
Last updated: February 02, 2026 5:33 AM ET
Data refreshes hourly during market hours. Next update: 6:33 AM
Data refreshes hourly during market hours. Next update: 6:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RNAZ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$213 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$13 | 63 BUY |
